Jacobs Awarded Contract from Bristol-Myers Squibb

first_imgBusiness Districts News Jacobs Awarded Contract from Bristol-Myers Squibb Delivering State-of-the-Art Large-Scale Biologics Manufacturing Facility in Ireland Published on Tuesday, February 24, 2015 | 10:56 am 7 recommended0 commentsShareShareTweetSharePin it Business News Get our daily Pasadena newspaper in your email box. Free.Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m. EVENTS & ENTERTAINMENT | FOOD & DRINK | THE ARTS | REAL ESTATE | HOME & GARDEN | WELLNESS | SOCIAL SCENE | GETAWAYS | PARENTS & KIDS Name (required)  Mail (required) (not be published)  Website  Community News Your email address will not be published. Required fields are marked * More Cool Stuff HerbeautyThis Trend Looks Kind Of Cool!HerbeautyHerbeautyHerbeauty6 Strong Female TV Characters Who Deserve To Have A SpinoffHerbeautyHerbeautyHerbeautyStop Eating Read Meat (Before It’s Too Late)HerbeautyHerbeautyHerbeauty11 Signs Your Perfectionism Has Gotten Out Of ControlHerbeautyHerbeautyHerbeauty10 Ways To Get Into Shape You’ve Never Tried BeforeHerbeautyHerbeautyHerbeauty10 Vietnamese Stunners That Will Take Your Breath AwayHerbeautyHerbeauty Make a commentcenter_img Pasadena Will Allow Vaccinated People to Go Without Masks in Most Settings Starting on Tuesday Home of the Week: Unique Pasadena Home Located on Madeline Drive, Pasadena Subscribe Pasadena’s ‘626 Day’ Aims to Celebrate City, Boost Local Economy First Heatwave Expected Next Week Community News faithfernandez More » ShareTweetShare on Google+Pin on PinterestSend with WhatsApp,Virtual Schools PasadenaHomes Solve Community/Gov/Pub SafetyPASADENA EVENTS & ACTIVITIES CALENDARClick here for Movie Showtimes Jacobs Engineering Group Inc. (NYSE:JEC) announced today that it received a contract from Bristol-Myers Squibb Company to provide architectural and engineering services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland.The facility is being designed to produce multiple therapies for the company’s robust and growing portfolio of approved and investigational biologic medicines, and to increase Bristol-Myers Squibb’s biologics manufacturing capacity. The new facility is expected to include multiple large scale bioreactors, a purification area, as well as office and laboratory space. Bristol-Myers Squibb’s Board of Directors has approved initial funding that will support the first phase of the project, with the full cost of the facility expected to be finalized in the second half of 2015.In making the announcement, Jacobs Group Vice President Chris Nagel stated, “With more than 40 years of experience and a proven track record of success in executing pharmaceutical projects in Ireland, we are uniquely positioned to work with Bristol-Myers Squibb on this project. We look forward to meeting their project delivery needs and further developing our relationship.”The facility is estimated to be operational in 2019.Jacobs, one of the world’s largest and most diverse providers of technical professional and construction services, consistently delivers award-winning pharmaceutical and biotechnology projects worldwide. Top of the News last_img read more